163 related articles for article (PubMed ID: 35634429)
1. Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma.
Lurje I; Czigany Z; Bednarsch J; Gaisa NT; Dahl E; Knüchel R; Miller H; Ulmer TF; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
Liver Cancer; 2022 Apr; 11(2):162-173. PubMed ID: 35634429
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma.
Lurje I; Gaisa NT; Dahl E; Knüchel R; Strnad P; Trautwein C; Tacke F; Neumann UP; Czigany Z; Lurje G
Sci Rep; 2023 Jul; 13(1):12283. PubMed ID: 37507547
[TBL] [Abstract][Full Text] [Related]
3. Nerve Fibers in the Tumor Microenvironment as a Novel Biomarker for Oncological Outcome in Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.
Bednarsch J; Kather J; Tan X; Sivakumar S; Cacchi C; Wiltberger G; Czigany Z; Ulmer F; Neumann UP; Heij LR
Liver Cancer; 2021 Jun; 10(3):260-274. PubMed ID: 34239812
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of tumor-associated unilateral portal vein occlusion in perihilar cholangiocarcinoma.
Bednarsch J; Czigany Z; Heij LR; Luedde T; Wiltberger G; Dulk MD; Bruners P; Lang SA; Ulmer TF; Neumann UP
HPB (Oxford); 2021 Oct; 23(10):1565-1577. PubMed ID: 33934958
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.
Lurje I; Czigany Z; Eischet S; Bednarsch J; Ulmer TF; Isfort P; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
Hepatol Commun; 2022 Sep; 6(9):2400-2417. PubMed ID: 35616275
[TBL] [Abstract][Full Text] [Related]
7. Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection.
Miller H; Czigany Z; Lurje I; Reichelt S; Bednarsch J; Strnad P; Trautwein C; Roderburg C; Tacke F; Gaisa NT; Knüchel-Clarke R; Neumann UP; Lurje G
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352897
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
9. Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
Mantas A; Liu D; Otto CC; Heij LR; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
Sci Rep; 2024 Jan; 14(1):1644. PubMed ID: 38238432
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of in-hospital transfusion of fresh frozen plasma in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
Bednarsch J; Czigany Z; Heij LR; Luedde T; Loosen SH; Dulk MD; Bruners P; Lang SA; Ulmer TF; Neumann UP
Eur J Surg Oncol; 2022 Mar; 48(3):604-614. PubMed ID: 34565633
[TBL] [Abstract][Full Text] [Related]
11. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
[TBL] [Abstract][Full Text] [Related]
12. Body composition is associated with postoperative complications in perihilar cholangiocarcinoma.
Wang G; Mantas A; Heij LR; Al-Masri TM; Liu D; Heise D; Schmitz SM; Olde Damink SWM; Luedde T; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38164056
[TBL] [Abstract][Full Text] [Related]
13. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup.
Zhao J; Zhang W; Zhang J; Chen YT; Ma WJ; Liu SY; Li FY; Song B
Cancer Manag Res; 2020; 12():13111-13123. PubMed ID: 33376403
[TBL] [Abstract][Full Text] [Related]
14. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection.
Leng KM; Liu YP; Wang ZD; Zhong XY; Liao GQ; Kang PC; Cui YF; Jiang XM
Onco Targets Ther; 2017; 10():2257-2266. PubMed ID: 28461760
[TBL] [Abstract][Full Text] [Related]
15. The rs1008562, rs2234671, and rs3138060 polymorphisms of the CXCR1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Briseño-Zuno CJ; Figuera LE; Sánchez-López JY; Zúñiga-González GM; Puebla-Pérez AM; Gómez-Meda BC; Montoya-Fuentes H; Delgado-Saucedo JI
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9990-10002. PubMed ID: 33090404
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.
Liu ZP; Chen WY; Wang ZR; Liu XC; Fan HN; Xu L; Pan Y; Zhong SY; Xie D; Bai J; Jiang Y; Zhang YQ; Dai HS; Chen ZY
Front Oncol; 2022; 12():849053. PubMed ID: 35530316
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Gerger A; El-Khoueiry A; Zhang W; Yang D; Singh H; Bohanes P; Ning Y; Winder T; Labonte MJ; Wilson PM; Benhaim L; Paez D; El-Khoueiry R; Absenger G; Lenz HJ
Clin Cancer Res; 2011 Sep; 17(17):5783-92. PubMed ID: 21791631
[TBL] [Abstract][Full Text] [Related]
18. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
Hau HM; Devantier M; Jahn N; Sucher E; Rademacher S; Seehofer D; Sucher R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638257
[TBL] [Abstract][Full Text] [Related]
19. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
20. Investigating the impact of the genetic variant CXCR1 (rs2234671) in individuals with urinary tract infections.
Naser HH; Kadhim MJ; Almhanna H
Hum Antibodies; 2024; 32(1):9-18. PubMed ID: 38339925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
